ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 135,64
0,54%
Dow Jones
39 671,04
0,00%
DAX
18 765,56
0,45%
Brent Oil
82,415
1,09%
Bitcoin
69 760,00
0,95%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Milestone Pharmaceuticals Inc (MIST)

  7. Milestone Pharmaceuticals Inc (MIST) Actualités

MIST Milestone Pharmaceuticals Inc

1,76
0,01 (0,57%)
Avant marché
Dernière mise à jour : 14:29:03
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Milestone Pharmaceuticals Inc MIST NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,01 0,57% 1,76 14:29:03
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,75
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/5/202414:00GLOBEMilestone Pharmaceuticals Partners with Arrhythmia Alliance..
13/5/202413:34EDGAR2Form 8-K - Current report
13/5/202412:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/3/202415:00EDGAR2Form 8-K - Current report
01/3/202422:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/2/202413:00GLOBEMilestone Pharmaceuticals Announces Pricing of $30.0 Million..
28/2/202422:37GLOBEMilestone Pharmaceuticals Announces Proposed Public Offering..
26/2/202413:06EDGAR2Form 8-K - Current report
15/2/202402:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202413:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/12/202314:54DJNMilestone Pharmaceuticals Shares Sink 24% After Receiving..
26/12/202313:57DJNMilestone Pharmaceuticals' Etripamil Nasal Spray Application..
26/12/202313:15EDGAR2Form 8-K - Current report
21/11/202313:00PRNCAMilestone Pharmaceuticals to Present at the Piper Sandler..
13/11/202313:05EDGAR2Form 8-K - Current report
13/11/202312:57PRNCAMilestone Pharmaceuticals Reports Third Quarter 2023..
13/11/202312:37EDGAR2Form 8-K - Current report
13/11/202312:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/11/202316:00PRNCAMilestone Pharmaceuticals Presents Positive Results from..
09/11/202322:43EDGAR2Form SC 13D - General statement of acquisition of beneficial..
07/11/202315:07EDGAR2Form 8-K - Current report
07/11/202313:00PRNUSMilestone Pharmaceuticals to Host Investor and Analyst..
24/10/202322:05EDGAR2Form 8-K - Current report
24/10/202313:00PRNUSMilestone Pharmaceuticals Announces Submission of New Drug..
06/10/202313:00PRNUSMilestone Pharmaceuticals Reports Inducement Grants Under..
27/9/202313:00PRNCAMilestone Pharmaceuticals Announces Etripamil AFib-RVR Study..
05/9/202313:00PRNCAMilestone Pharmaceuticals to Present at the H.C. Wainwright..
10/8/202313:40EDGAR2Form 8-K - Current report
10/8/202313:35PRNCAMilestone Pharmaceuticals Reports Second Quarter 2023..
10/8/202313:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/6/202313:00PRNUSMilestone Pharmaceuticals Announces Publication of Results..
01/6/202313:00PRNCAMilestone Pharmaceuticals to Present at the Jefferies..

Dernières Valeurs Consultées

NASDAQ
MIST
Milestone Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés